Cancer Genetics, Inc. Named to the 2012 Inc. 500|5000 List
9/4/2012 9:16:47 AM
Rutherford, NJ, Sept. 4, 2012 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (CGI), a leader in oncology-focused personalized medicine, today announced that Inc. magazine ranked the company #232 among private Healthcare companies, and #2859 overall on its sixth annual Inc. 500|5000 list, an exclusive ranking of the nation's fastest-growing private companies. The list represents a comprehensive look at the most important segment of the economy--America's independent entrepreneurs. This was the first year the Company has been on the list, and is among the first oncology-focused molecular diagnostic companies on the list.